全文获取类型
收费全文 | 868篇 |
免费 | 33篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 17篇 |
妇产科学 | 8篇 |
基础医学 | 300篇 |
口腔科学 | 17篇 |
临床医学 | 52篇 |
内科学 | 151篇 |
皮肤病学 | 52篇 |
神经病学 | 45篇 |
特种医学 | 16篇 |
外科学 | 45篇 |
综合类 | 123篇 |
预防医学 | 24篇 |
眼科学 | 18篇 |
药学 | 18篇 |
中国医学 | 12篇 |
肿瘤学 | 29篇 |
出版年
2024年 | 1篇 |
2023年 | 3篇 |
2022年 | 3篇 |
2021年 | 5篇 |
2020年 | 8篇 |
2019年 | 3篇 |
2018年 | 7篇 |
2017年 | 7篇 |
2016年 | 8篇 |
2015年 | 6篇 |
2014年 | 10篇 |
2013年 | 21篇 |
2012年 | 22篇 |
2011年 | 39篇 |
2010年 | 33篇 |
2009年 | 34篇 |
2008年 | 27篇 |
2007年 | 42篇 |
2006年 | 50篇 |
2005年 | 42篇 |
2004年 | 39篇 |
2003年 | 26篇 |
2002年 | 27篇 |
2001年 | 30篇 |
2000年 | 22篇 |
1999年 | 34篇 |
1998年 | 29篇 |
1997年 | 37篇 |
1996年 | 38篇 |
1995年 | 44篇 |
1994年 | 47篇 |
1993年 | 27篇 |
1992年 | 39篇 |
1991年 | 28篇 |
1990年 | 13篇 |
1989年 | 18篇 |
1988年 | 11篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 10篇 |
1984年 | 8篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有931条查询结果,搜索用时 15 毫秒
1.
CD14+单核细胞人类白细胞抗原DR表达率与脓毒症关系的研究 总被引:15,自引:0,他引:15
目的了解烧伤延迟复苏时CDl4^+单核细胞人类白细胞抗原DR(HLA—DR)表达率的变化,分析其与脓毒症的关系。方法选择烧伤面积大于30%TBSA的25例烧伤延迟复苏患者,于伤后1、3、7、14、28d取外周血,其中7例患者住院期间并发脓毒症,于脓毒症发生后连续2d亦取其外周血。另取20例健康体检者外周血作为对照。流式细胞仪检测CD14^+单核细胞HLA.DR表达率,酶联免疫吸附测定法检测血浆中肿瘤坏死因子α(TNF—α)、白细胞介素10(IL-10)的浓度。结果非脓毒症患者伤后1、3、7、14、28dCD14^+单核细胞HLA—DR表达率分别为(15±6)%、(74±5)%、(264±17)%、(284-16)%、(474-16)%,明显低于健康体检者[(924±10)%,P〈0.01];脓毒症患者发生脓毒症后1、2d,该指标亦明显低于健康体检者及非脓毒症患者伤后1、7、14、28d(P〈0.01)。脓毒症患者TNF—d检出率及TNF—α、IL-10浓度,均高于非脓毒症患者和健康体检者(P〈0.05或P〈0.01)。伤后1、7、28d,外周血CD14^+单核细胞HLA—DR表达率与IL—10浓度呈显著负相关(r分别为-0.9963、-0.7459、-0.8474,P〈0.01)。结论烧伤延迟复苏患者免疫功能低下,促炎性介质释放量增加,并发脓毒症时则更为严重。外周血CD14^+单核细胞HLA—DR表达率可作为动态检测患者免疫功能状态的有效指标。 相似文献
2.
A. C. Lazaris G. E. Theodoropoulos K. Aroni A. Saetta P. S. Davaris 《Virchows Archiv : an international journal of pathology》1995,426(5):461-467
The clinical course of malignant melanomas is frequently unpredictable, although a number of prognostically useful variables can be identified. There is a need for additional markers of prognostic value. In a series of 60 malignant cutaneous melanomas, we analysed the immunohistochemical expression of c-myc proto-oncogene, heat shock protein 70 (HSP70) and HLA-DR molecules in order to investigate their prognostic significance. C-myc, HSP70 and HLA-DR were expressed in 43.3%, 56.6% and 38.3% of all melanoma cases, respectively. Advanced Clark levels (Clark III–V) were significantly associated with c-myc expression rate (P<0.05), HSP70 detection (P<0.01) and HLA-DR positivity (P<0.01). Increased Breslow thickness (>1.5 mm) was related to HLA-DR expression (P<0.05). High mitotic rate was closely associated with c-myc positivity (P<0.05), while HSP70 and HLA-DR expression separately correlated to clinical stage of the disease (P<0.05). The evaluation of these variables may be of immunological and prognostic significance. They were found to be associated with melanocyte subpopulations of the vertical growth phase which are arguably characterized by an increased invasive potential. 相似文献
3.
4.
Manoussos M. Konstadoulakis MD Michael Vezeridis MD Emi Hatziyianni MD Constantine P. Karakousis MD PhD Bernard Cole PhD Kirby I. Bland MD Harold J. Wanebo MD 《Annals of surgical oncology》1998,5(3):253-260
Background: Oncogenes and other molecular tumor markers that predict tumor aggressiveness may allow individualization and optimization of surgical therapy of intermediate-thickness malignant melanoma. We examined the expression of selected markers, including the HLA-DR antigen, the heat shock protein-70 (HSP-70), and the c-myc oncogene in primary melanoma and regional nodes and related these findings to metastatic potential and survival.
Methods: Forty patients with primary melanoma (1.5–4.0 mm) were studied, all of whom had prophylactic lymph node dissection and were followed for 18 months to 7 years. The primary tissue and nodes were examined using immunohistochemical techniques for the presence of HLA-DR antigen and HSP-70 protein and the expression of the c-myc oncogene.
Results: Of 40 patients, there were 23 with lesions 1 to 2.9 mm thick and 17 with lesions 3 to 4 mm thick. Nodal metastases were present in 25 of the 40 patients who had elective node dissection. HLA-DR antibody stained the primary tumor in 10 patients (25%), but there was no correlation with survival in this group. HLA-DR antibody stained the stroma and cellular infiltrates surrounding the primary tumor in 28 of 40 patients; in this group there was a correlation of HLA-DR staining of the peritumoral stroma with improved survival overall. HLA-DR staining of the peritumoral stroma also influenced survival when patients were stratified by tumor thickness groups 1 to 2.9 mm and 3 to 4 mm and presence of nodal metastases. HSP-70 was demonstrated in the primary tumor in 25% of patients, who were also shown to have significantly improved survival when compared with those whose primary tumor did not stain with HSP-70. C-myc was expressed in the primary tumor in 25%, but showed no correlation with survival. None of these proteins correlated with or predicted the presence of nodal metastases.
Conclusion: We conclude that the use of specific molecular-oncogene markers in intermediate-thickness primary melanoma may identify patients at high risk for conventional treatment failure and reduced survival who may profit from more aggressive surgery, adjuvant therapy, or both.Presented at the 48th Annual Cancer Symposium of The Society of Surgical Oncology, Boston, Massachusetts, March 23–26, 1995. 相似文献
5.
V. A. Dunand C.-M. Ng J. A. Wade J. Bwayo F. A. Plummer K. S. MacDonald 《Tissue antigens》1997,49(4):397-402
The genes of the major histocompatibility complex (MHC) are amongst the most polymorphic loci known in the human population. The population genetics of the MHC encoded HLA loci of sub-Saharan Africa are of major interest because of their particular genetic diversity. Here we report on the HLA-DR 52- and 51-associated determinants of the DRB1 loci observed in 165 East African individuals studied in Nairobi, Kenya. The HLA-DR typing was done by serologic and by molecular DNA techniques (PCR-SSOP). The most frequent allele identified was DRB1*1101, followed by DRB1*1503 and DRB1*1302. Some unexpected alleles were repeatedly identified: DRB1*1108, DRB1*1316 and DRB1*1421. Most oftheDR 52-and 51-associated DRB1 alleles were correctly identified by serology as part of the DR3, DR5, DR6 and DR2 groups respectively. The HLA-DRB1 profile reported here corroborates previous genetic and linguistic data supporting the concept that the Eastern African Black population is genetically distinct from other African Black populations. This has important implications in public health issues related to the genetic profile of a population (transplantation, vaccine design for example). 相似文献
6.
7.
8.
为了探讨创伤后机体细胞免疫、体液免疫及红细胞免疫功能障碍与外周血单个核细胞HLA-DR表达率之间的关系,本文选择了30例重度复合伤病人。在住院治疗期间,连续观察了患者受伤当日、伤后第3、10、20d及出院前一天外周血单个核细胞HLADR表达率的变化及其与细胞免疫、体液免疫及红细胞免疫功能状况之间的相关性,发现创伤病人自受伤当日至出院前外周血单个核细胞膜上HLA-DR表达率的变化无统计学意义(P>0.05),提示创伤后免疫功能障碍不是由于外周血单个核细胞HLA-DR表达异常所致。 相似文献
9.
10.